https://i1.wp.com/treatcancer.com/wp-content/uploads/2015/12/Kaposis_Sarcoma_Lesions.jpg?fit=1012%2C675&ssl=1 675 1012 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-05 23:48:272018-10-11 19:42:15What is Kaposi Sarcoma?
Kaposi sarcoma is rare type of cancer that causes tumors to form in the skin; mucous membranes lining the mouth, nose, and throat; lymph nodes; or other organs. Tumors caused by Kaposi sarcoma are usually purple and are made of cancer cells, new blood vessels, red blood cells, and white blood cells. Most cancers begin in one part of the body and spread to others; in the case Kaposi sarcoma, lesions may begin in more than one place in the body at the same time.
https://i0.wp.com/treatcancer.com/wp-content/uploads/2015/12/Gray602.png?fit=500%2C505&ssl=1 505 500 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-12-01 23:29:522015-12-15 23:41:53Skin Lymphoma
Skin lymphoma is a rare type of cancer that originates in white blood cells in the skin. Lymphoma is a type of cancer that develops in white blood cells called lymphocytes. Lymphocytes are an integral part of the body’s immune system. They are found in lymph nodes, which are small clusters of immune tissue located at various locations throughout the body, as well as in other areas of the body, such as the bone marrow, spleen, and other organs, including the skin.
https://i0.wp.com/treatcancer.com/wp-content/uploads/2015/12/cancer-cells-541954_640.jpg?fit=640%2C416&ssl=1 416 640 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-11-30 23:13:042018-11-29 21:02:03Atezolizumab Shows Early Positive Data for Treating Metastatic Melanoma
A study released by Swiss pharmaceutical company Roche in November shows early positive data for new cancer drug atezolizumab, which was used in combination with another drug to treat advanced melanoma.
https://i1.wp.com/treatcancer.com/wp-content/uploads/2015/08/business_open-pharma_2.png?fit=520%2C292&ssl=1 292 520 Jay Hansbrough https://treatcancer.com/wp-content/uploads/2015/08/SERO-logo-PNG-450x174.png Jay Hansbrough2015-08-16 01:57:072018-04-18 14:48:18FDA approves new skin cancer drug for basal cell carcinoma
The U.S. Food and Drug Administration (FDA) has approved a new skin cancer drug designed to treat basal cell carcinoma. The drug, Odomzo, will be used to treat locally advanced basal cell carcinomas in patients where the disease has returned after the original tumor was surgically removed. The drug will also be an option for patients who are not candidates for surgery or radiation treatment.